ASTROTECH Corp ASTC
Nasdaq · XNAS · stock · Laboratory Analytical Instruments
Chart by TradingView
2/9
Piotroski F — financial health
-24.48
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $1.0M | -$13.8M | $475,000 | -$13.8M | $22.1M |
| 2024 | $1.7M | -$11.7M | $751,000 | -$10.3M | $34.8M |
| 2023 | $750,000 | -$9.6M | $306,000 | -$9.5M | $44.7M |
| 2022 | $869,000 | -$8.3M | $192,000 | -$7.4M | $53.2M |
| 2021 | $334,000 | -$7.6M | $36,000 | -$7.6M | $61.2M |
| 2020 | $488,000 | -$8.3M | $39,000 | -$6.9M | $625,000 |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -24.48 (distress)
- Working capital / assets 0.723
- Retained earnings / assets -9.295
- EBIT / assets -0.546
- Equity / liabilities 4.52
Source: SEC EDGAR filings · CIK 0001001907 · as of 2025-06-30. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.